Glioma-induced DNMT3A-dependent reduction of DNA methylation in microglia promotes a transient anti-tumoral phenotype.
Mathilde Cheray, Adriana‐Natalia Murgoci, Adamantia F. Fragopoulou, Carlos Fernando Dias Rodrigues, Martin Škandík, Ahmed M. Osman, Christine Hong, Guillermo Vázquez-Cabrera, Lara Frieß, Lena-Maria Carlson, Shigeaki Kanatani, Yue Li, Anastasios E. Damdimopoulos, Per Uhlén, Fredrik Kamme, , Bertrand Joseph
This study shows that glioma-induced DNMT3A reduction in microglia leads to DNA demethylation and an anti-tumoral phenotype, suggesting DNMT3A as a therapeutic target for glioblastoma.
bioRxiv · Feb 22, 2025 · PreprintImmunology